Organigram (TSE:OGI) Hits New 1-Year Low – Should You Sell?

Organigram Holdings Inc. (TSE:OGI)’s stock price hit a new 52-week low during trading on Friday . The stock traded as low as C$1.77 and last traded at C$1.78, with a volume of 212154 shares. The stock had previously closed at C$1.83.

Wall Street Analyst Weigh In

OGI has been the topic of several recent analyst reports. Canaccord Genuity Group dropped their target price on Organigram from C$3.60 to C$3.15 and set a “speculative buy” rating on the stock in a report on Monday, December 9th. ATB Capital decreased their price target on shares of Organigram from C$5.25 to C$3.50 in a research report on Tuesday, December 17th.

Organigram Stock Performance

The company has a quick ratio of 2.62, a current ratio of 3.36 and a debt-to-equity ratio of 3.07. The stock has a market cap of C$224.85 million, a price-to-earnings ratio of -3.85, a price-to-earnings-growth ratio of 0.42 and a beta of 1.13. The company’s 50-day simple moving average is C$2.19 and its 200-day simple moving average is C$2.30.

Organigram Company Profile

Organigram Inc is a Canadian licensed producer of cannabis products. Organigram focuses on producing exceptional, indoor-grown cannabis for patients and adult recreational consumers, as well as developing global business partnerships.